RNXT
RenovoRx, Inc.NASDAQHealthcare$0.98-4.91%ClosedMarket Cap: $35.9M
As of 2026-04-06
Insider Statistics (Q1 2026)
Purchases
8
Sales
0
Buy/Sell Ratio
0.00
Total Bought
$7.00
Total Sold
$0.00
Recent Insider Trades
| Filing Date | Name | Type | Action | Shares | Price | Shares After |
|---|---|---|---|---|---|---|
| Fri Mar 27 | VOLL MARK | officer: Chief Financial Officer | Sell | 12,380 | $0.00 | 37,380 |
| Tue Mar 24 | Marton Laurence | director | Buy | 4,860 | $1.93 | 4,860 |
| Tue Mar 24 | Bagai Shaun | director, officer: Chief Executive Officer | Buy | 24,300 | $0.00 | 313,357 |
| Tue Mar 24 | Bagai Shaun | director, officer: Chief Executive Officer | Buy | 12,150 | $1.93 | 12,150 |
| Tue Mar 24 | VOLL MARK | officer: Chief Financial Officer | Buy | 97,200 | $0.00 | 97,200 |
| Tue Mar 24 | Marton Laurence | director | Buy | 9,720 | $0.00 | 9,720 |
| Tue Mar 24 | VOLL MARK | officer: Chief Financial Officer | Sell | 0 | $0.00 | 25,000 |
| Tue Mar 24 | VOLL MARK | officer: Chief Financial Officer | Buy | 48,600 | $1.93 | 48,600 |
| Thu Jan 22 | Agah Ramtin | director, officer: Chief Medical Officer | Buy | 10,000 | $1.00 | 798,460 |
| Mon Jan 05 | Agah Ramtin | director, officer: Chief Medical Officer | Buy | 9,795 | $0.86 | 788,460 |
| Fri Jan 02 | Agah Ramtin | director, officer: Chief Medical Officer | Buy | 205 | $0.83 | 778,665 |